PowerPoint on Contemportary Pharmaceutical Compounding from Dr. Loyd Allen

Here is a PowerPoint Presentation entitled Contemporary Pharmaceutical Compounding from a well-respected expert in the field Dr. Loyd Allen.  To view the PowerPoint can be viewed here.

Powerpoint Presentation on Animal Drug Compounding

Neal Batalier, DVM for the FDA Center for Veterinary Medicine, presented this Powerpoint at the AAVPT 14th.  While it  is dated 2005, it still contains valuable information.  Note, however, that some portions such as those regarding current investigations, etc. are outdated.  To view the Powerpoint, click here.

Coverage of Compounded Medications in Minnesota

Compound Drugs Revised: 01-23-2012 Compound Drugs A compound drug consists of two or more ingredients. The quantity at the line level should reflect the way the NDC is normally billed. Example: if the NDC is normally billed per milliliter, the quantity at the line should be the total number of milliliters dispensed for the entire prescription – not the number of containers of normal saline used. Pharmacies will be paid only for the ingredients which are normally covered by DHS. Commercially Available Products If room stable commercially available products are compounded, reimbursement is limited to the rate of the commercially available product (WAC plus 2% or the SMAC plus dispensing fee). Compounded Products, Preparations, and Oral Drugs Compounded liquid oral drugs (e.g., solutions, suspensions, emulsions) are covered only for children and for aphagic adult recipients, and only when a commercial liquid version of the drug is not available. Compounded capsules are covered only if a tablet or capsule commercial version of the drug is not available in the strength prescribed, and if the appropriate strength cannot be achieved using half or quarter tablets. Compounded Topical Products Compounded topical products are not covered when a product that contains the same combination of active ingredients in the same strengths is commercially available from a pharmaceutical manufacturer, regardless of the package size that is commercially available. Example: If the prescription is for 15 grams of an ointment and the commercially available version is available only in 30 gram tubes, MHCP will not cover 15 grams of the compounded product. Compounded Intravenous (IV) & Total Parenteral Nutritional (TPN) Drugs Compounded IV and TPN drugs are covered according to FDA guidelines regarding approved indications and preparation.

Alabama Medicaid Physician Administered Drugs: When will Compounded Drugs for Non-Pharmacy Providers be Covered

Compound Drugs for Non-Pharmacy Providers
The compound drug must not be commercially available, and the active
ingredient of the compound drug must follow coverage policy of drugs
(FDA approved, non-DESI, not obsolete, etc).
When a provider administers a drug that must be purchased from a
compounding pharmacy because it is no longer commercially available
(e.g. due to the manufacturer no longer marketing the product), the
applicable claim form may be submitted for consideration of payment.  The
billed amount should represent the lesser of the actual acquisition cost for
the drug or Medicaid rate on file (ASP CMS pricing) at the time of service.
When billing the HCPCS code for a purchased compounded drug, only
one NDC can be used per procedure code.  Providers must use the
HCPCS procedure code, billing units and corresponding covered NDC
number on the claim form; for example, J1094 Injection, dexamethasone
acetate, 1 mg.  The NDC billed should be the one that represents the drug
as described in the HCPCS code definition, in this case dexamethasone
acetate.  See the section entitled “Calculation of Billing Units and
Wastage” for information on calculating billing units.
The Agency does not reimburse non-pharmacy providers for prescription
compounding time or non-covered ingredients used in the compounding
process.  The Alabama Medicaid Agency only reimburses for the
compounding time by the billing of NDC numbers through the Pharmacy
Program.

Taken from January 2012 manual found here